ArticleScience translational medicine2022

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.

Yueh-Ming Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.